We are live on ! Find out more
MSL

Mackay Shields LLC Portfolio holdings

AUM $2.73B
1-Year Est. Return 2.13%
This Fund
S&P 500
This Quarter Est. Return
+0.7%
1 Year Est. Return
+2.13%
3 Year Est. Return
+7.81%
5 Year Est. Return
+19%
10 Year Est. Return
+113.23%
AUM
$10.6B
AUM Growth
-$29M
Cap. Flow
-$2.95B
Cap. Flow %
-27.83%
Top 10 Hldgs %
25.65%
Holding
722
New
10
Increased
39
Reduced
477
Closed
11

Top Buys

Rank Stock Value
1
MRNA icon
Moderna
MRNA
+$19.8M
2
TSM icon
TSMC
TSM
+$10.7M
3
MTCH icon
Match Group
MTCH
+$6.4M
4
VST icon
Vistra
VST
+$5.66M
5
CPLB
NYLI MacKay Core Plus Bond ETF
CPLB
+$4.99M

Top Sells

Rank Stock Value
1
LRCX icon
Lam Research
LRCX
+$36.4M
2
MSFT icon
Microsoft
MSFT
+$10.8M
3
AAPL icon
Apple
AAPL
+$10.4M
4
ALXN
Alexion Pharmaceuticals
ALXN
+$6.41M
5
NEA icon
Nuveen AMT-Free Quality Municipal Income Fund
NEA
+$6.18M

Sector Composition

Rank Sector Weight
1 Technology 13.42%
2 Financials 7.36%
3 Healthcare 6.77%
4 Consumer Discretionary 6.29%
5 Communication Services 5.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FIS icon
126
Fidelity National Information Services
FIS
$21.5B
$11.5M 0.11%
94,535
-2,621
-3% -$352K
TMUS icon
127
T-Mobile US
TMUS
$193B
$11.5M 0.11%
89,857
-1,947
-2% -$271K
DUK icon
128
Duke Energy
DUK
$102B
$11.4M 0.11%
117,323
-3,403
-3% -$352K
CCI icon
129
Crown Castle
CCI
$32.7B
$11.4M 0.11%
65,957
-1,913
-3% -$370K
COF icon
130
Capital One
COF
$124B
$11M 0.1%
68,125
-2,878
-4% -$470K
NRK icon
131
Nuveen New York AMT-Free Quality Municipal Income Fund
NRK
$900M
$10.9M 0.1%
791,405
+142,815
+22% +$2.03M
EQIX icon
132
Equinix
EQIX
$107B
$10.8M 0.1%
13,702
-398
-3% -$331K
BDX icon
133
Becton Dickinson
BDX
$43.1B
$10.8M 0.1%
44,878
-1,927
-4% -$473K
EW icon
134
Edwards Lifesciences
EW
$47.6B
$10.7M 0.1%
94,859
-2,750
-3% -$314K
EL icon
135
Estee Lauder
EL
$29B
$10.6M 0.1%
35,377
-1,026
-3% -$335K
CME icon
136
CME Group
CME
$92.2B
$10.6M 0.1%
54,864
-1,456
-3% -$295K
CI icon
137
Cigna
CI
$76.6B
$10.4M 0.1%
52,022
-2,030
-4% -$441K
SHW icon
138
Sherwin-Williams
SHW
$78.3B
$10.3M 0.1%
36,939
-667
-2% -$195K
CSX icon
139
CSX Corp
CSX
$98.6B
$10.3M 0.1%
344,652
-9,045
-3% -$290K
SO icon
140
Southern Company
SO
$110B
$10M 0.09%
161,489
-4,684
-3% -$302K
FISV
141
Fiserv Inc
FISV
$27.2B
$9.89M 0.09%
91,167
-2,116
-2% -$236K
ICE icon
142
Intercontinental Exchange
ICE
$82.4B
$9.85M 0.09%
85,819
-2,490
-3% -$296K
CL icon
143
Colgate-Palmolive
CL
$72.6B
$9.79M 0.09%
129,550
-3,744
-3% -$297K
REGN icon
144
Regeneron Pharmaceuticals
REGN
$68.8B
$9.7M 0.09%
16,022
-463
-3% -$287K
ADSK icon
145
Autodesk
ADSK
$44.3B
$9.62M 0.09%
33,720
-1,096
-3% -$335K
MHI
146
DELISTED
Pioneer Municipal High Income Fund
MHI
$9.59M 0.09%
790,568
-16,859
-2% -$215K
BSX icon
147
Boston Scientific
BSX
$65.8B
$9.42M 0.09%
217,095
-6,289
-3% -$278K
ATVI
148
DELISTED
Activision Blizzard
ATVI
$9.19M 0.09%
118,795
-3,438
-3% -$287K
HCA icon
149
HCA Healthcare
HCA
$84.8B
$9.16M 0.09%
37,740
-3,992
-10% -$976K
ITW icon
150
Illinois Tool Works
ITW
$81.4B
$9.11M 0.09%
44,070
-1,272
-3% -$287K
4 5
6
7 8

Similar funds

GC
Giverny Capital Montreal, Quebec, Canada $2.73B AUM 14.09% 1-Year Est. Return
PA
Profund Advisors Bethesda, Maryland $2.72B AUM 47.27% 1-Year Est. Return
MASUI
MIRAE ASSET SECURITIES (USA) INC. New York $2.72B AUM 36.56% 1-Year Est. Return
LMIM
Lockheed Martin Investment Management Bethesda, Maryland $2.73B AUM 28.24% 1-Year Est. Return
XL
XN LP New York $2.72B AUM 46.67% 1-Year Est. Return
PCM
Patient Capital Management Baltimore, Maryland $2.74B AUM 43.59% 1-Year Est. Return
CIAS
CBIZ Investment Advisory Services Independence, Ohio $2.74B AUM 14.19% 1-Year Est. Return
CA
Cornerstone Advisors Asheville, North Carolina $2.72B AUM 22.17% 1-Year Est. Return

Mackay Shields LLC's Q3 2021 Portfolio in Review

As of Q3 2021, Mackay Shields LLC held 722 positions worth $10.6B, down 0.27% from $10.6B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Mackay Shields LLC withdrew a net $2.95B in Q3 2021, closing 11 positions and reducing 477 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $6.41M position sold in full.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 14% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Mackay Shields LLC opened a new position in Moderna worth $20.7M.

  • Mackay Shields LLC's largest Q3 2021 buy was Moderna: 53,663 shares worth $20.7M.
  • Mackay Shields LLC added most to TSMC in Q3 2021, an estimated $10.7M increase.
  • Mackay Shields LLC's biggest Q3 2021 reduction was Lam Research, cutting an estimated $36.4M.
  • Mackay Shields LLC fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $6.41M.
  • Mackay Shields LLC's ten largest holdings make up 26% of its $10.6B portfolio in Q3 2021.
  • Mackay Shields LLC opened 10 new positions and closed 11 in Q3 2021.
  • Mackay Shields LLC's portfolio value fell 0.27% quarter-over-quarter to $10.6B.

Based on Mackay Shields LLC's 13F filing for Q3 2021, filed 12 Nov 2021.